Artelo Biosciences Set to Unveil Innovative Findings on ART12.11 Tablets Versus Epidiolex at the Upcoming IMCCB-25 Conference in Bern, Switzerland
SOLANA BEACH, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company, announced it will